13-Valent Pneumococcal Polysaccharide Conjugate Vaccine

Pfizer Europe MA EEIG🇨🇳 National Medical Products Administration

Approval Id: 8BYtKni27Ja
Approval Number: 国药准字SJ20160042
Generic Name: 13价肺炎球菌多糖结合疫苗
Generic Name En: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
Trade Name: 沛儿13
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 0.5ml/支，每0.5ml各型多糖含量为：1、3、4、5、6A、7F、9V、14、18C、19A、19F和23F型各2.2μg，6B型4.4μg
Reg Date: 2026-01-22
Expired Date: 2030-12-21
Company Name: Pfizer Europe MA EEIG
Production Company Name: Pfizer Ireland Pharmaceuticals
Company Detail Path: /organization/pfizer-europe-ma-eeig
Production Company Detail Path: /organization/pfizer-ireland-pharmaceuticals

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 22, 2026

Approval ID

8BYtKni27Ja

Type

生物制品